Stocks including GAIL (India), Vodafone Idea, NTPC, Concord Biotech, HAL, IRB Infrastructure, NTPC Green Energy and BPCL will be in the spotlight on Wednesday, April 09.
A significant portion of the investments is directed toward the state’s Green Pharma City initiative, with 17 MoUs signed
The company further said, though this was “purely unintentional”, such mistakes are “not uncommon for the patent office therefore Patent Law provides provisions to rectify such mistakes”. The vaccine maker added it has “great respect for ICMR and is thankful to the agency for their continuous support on various projects”.
Earlier this month, a team of researchers at BHU conducted a one-year follow-up study on Covaxin, manufactured by Hyderabad-based Bharat Biotech. According to the study, nearly one-third of the individuals who received the Covaxin vaccine reported 'adverse events of special interest' or AESI.
Covaxin side-effects: Bharat Biotech said that for a study to be effective, informative and to avoid investigator bias, a few data points are required, including the AESI safety profile of the subjects prior to the participation in the study.
It has reopened its call for expressions of interest twice in the past three months
AstraZeneca has said that in “very rare cases”, its Covid-19 vaccine can cause low platelet count and a blood clot-related side effect – Thrombosis Thrombocytopenia Syndrome (TTS)
Collaboration aims at enhancing production and security of supply for Oral Polio Vaccines OPV
RVNL, SAIL, Mazagon Dock ex-dividend stocks today, RR Kabel shares listing in Top News on September 20: Share markets, Bank Nifty outlook, Signature Global IPO to open, Aprilia RS 457 to be unveiled in India also in focus in top stories today.
SBI, M&M, JK Tyre Q1 Results, Concord Biotech IPO on August 4: Kotak Mahindra Bank, Kalyan Jewellers ex-dividend stocks, share markets and Nifty outlook, OnePlus Nord CE 3 5G sale on Amazon in focus.
The Serum Institute was among the first two vaccine manufacturers who rolled out Covid vaccines in India. Pune-based Serum produced Covishield in partnership with UK's AstraZeneca while Hyderabad-based Bharat Biotech rolled out Covaxin.
Silver Rally Turns Explosive: $100 Crossed, $115 Next?
Tata Elxsi Q3 Results: Profit Slides, Stock Under Pressure Despite Margin Recovery




